Recombinant human serum albumin (OsrHSA) has emerged as an important innovation in the sphere of biopharmaceuticals, presenting promising progress across various healthcare and industrial programs. With its structural similarity to Obviously derived human serum albumin, OsrHSA provides a safer, more trustworthy alternate for therapeutic use, partic